PubMed:7885039
Annnotations
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 203-242 | DRI_Background | denotes | It is well documented that treatment of |
| T2 | 260-388 | DRI_Background | denotes | cells with 10(-7) M all-trans retinoic acid (all-trans RA) induces neutrophil differentiation, whereas treatment with 10(-7) M 1 |
| T3 | 415-464 | DRI_Background | denotes | D3(D3) induces differentiation towards monocytes. |
| T4 | 909-1069 | DRI_Approach | denotes | Treatment of serum-free grown HL60 cells with 5 x 10(-7) M all-trans RA or 9-cis RA resulted in sub-optimal neutrophil differentiation (up to 25% mature cells). |
| T5 | 1070-1161 | DRI_Approach | denotes | As shown for all-trans RA, 9-cis RA cooperated with D3 to promote monocyte differentiation. |
| T6 | 1162-1547 | DRI_Approach | denotes | Culture of HL60 cells in 5 x 10(-7) M 9-cis RA together with a wide range of concentrations of D3 resulted in promotion of neutrophil differentiation at 10(-15)-10(-12) D3, a failure to differentiate and apoptosis at 10(-11)-10(-10) M D3, followed by co-operativity between 9-cis RA and 5 x 10(-9) M D3 in inducing monocyte differentiation in the absence of neutrophil differentiation. |
| T7 | 1548-1687 | DRI_Approach | denotes | Similar results were obtained when HL60 cells were treated with 5 x 10(-7) all-trans RA together with a wide range of concentrations of D3. |
| T8 | 1688-1963 | DRI_Background | denotes | Cross titration analyses of the effects of 9-cis RA and D3 on HL60 cell differentiation were undertaken to determine the boundaries of the concentrations of each agent, alone and in combination, that give rise to optimal neutrophil and monocyte differentiation of HL60 cells. |
| T9 | 1964-2139 | DRI_Approach | denotes | The observed cooperativities between either 9-cis RA or all-trans RA and D3 have important implications for the use of combinations of these agents in differentiation therapy. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-23 | cell_line | denotes | HL60 cells |
| T2 | 133-144 | cell_type | denotes | neutrophils |
| T3 | 148-157 | cell_type | denotes | monocytes |
| T4 | 243-265 | cell_line | denotes | serum-grown HL60 cells |
| T5 | 327-337 | cell_type | denotes | neutrophil |
| T6 | 454-463 | cell_type | denotes | monocytes |
| T7 | 497-524 | cell_line | denotes | serum-free grown HL60 cells |
| T8 | 690-698 | cell_type | denotes | monocyte |
| T9 | 868-878 | cell_line | denotes | HL60 cells |
| T10 | 922-949 | cell_line | denotes | serum-free grown HL60 cells |
| T11 | 1173-1183 | cell_line | denotes | HL60 cells |
| T12 | 1583-1593 | cell_line | denotes | HL60 cells |
| T13 | 1750-1759 | cell_line | denotes | HL60 cell |
| T14 | 1952-1962 | cell_line | denotes | HL60 cells |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-202 | Sentence | denotes | Treatment of HL60 cells with various combinations of retinoids and 1 alpha,25 dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis. |
| S2 | 203-464 | Sentence | denotes | It is well documented that treatment of serum-grown HL60 cells with 10(-7) M all-trans retinoic acid (all-trans RA) induces neutrophil differentiation, whereas treatment with 10(-7) M 1 alpha,25 dihydroxyvitamin D3(D3) induces differentiation towards monocytes. |
| S3 | 465-731 | Sentence | denotes | In recent investigations, using serum-free grown HL60 cells, we observed that all-trans RA, at 10(-7) M, did not induce neutrophil differentiation and that all-trans RA, at 10(-8) M, reduced the D3 concentration required for monocyte differentiation to 5 x 10(-9) M. |
| S4 | 732-908 | Sentence | denotes | In this study, co-operative interactions between all-trans and 9-cis RA and D3 which promote neutrophil and monocyte differentiation of HL60 cells have been analysed in detail. |
| S5 | 909-1069 | Sentence | denotes | Treatment of serum-free grown HL60 cells with 5 x 10(-7) M all-trans RA or 9-cis RA resulted in sub-optimal neutrophil differentiation (up to 25% mature cells). |
| S6 | 1070-1161 | Sentence | denotes | As shown for all-trans RA, 9-cis RA cooperated with D3 to promote monocyte differentiation. |
| S7 | 1162-1547 | Sentence | denotes | Culture of HL60 cells in 5 x 10(-7) M 9-cis RA together with a wide range of concentrations of D3 resulted in promotion of neutrophil differentiation at 10(-15)-10(-12) D3, a failure to differentiate and apoptosis at 10(-11)-10(-10) M D3, followed by co-operativity between 9-cis RA and 5 x 10(-9) M D3 in inducing monocyte differentiation in the absence of neutrophil differentiation. |
| S8 | 1548-1687 | Sentence | denotes | Similar results were obtained when HL60 cells were treated with 5 x 10(-7) all-trans RA together with a wide range of concentrations of D3. |
| S9 | 1688-1963 | Sentence | denotes | Cross titration analyses of the effects of 9-cis RA and D3 on HL60 cell differentiation were undertaken to determine the boundaries of the concentrations of each agent, alone and in combination, that give rise to optimal neutrophil and monocyte differentiation of HL60 cells. |
| S10 | 1964-2139 | Sentence | denotes | The observed cooperativities between either 9-cis RA or all-trans RA and D3 have important implications for the use of combinations of these agents in differentiation therapy. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 13-23 | NP | denotes | HL60 cells |
| C2 | 67-97 | NP | denotes | 1 alpha,25 dihydroxyvitamin D3 |
| C3 | 109-157 | NP | denotes | differentiation towards neutrophils or monocytes |
| C4 | 243-265 | NP | denotes | serum-grown HL60 cells |
| C5 | 271-318 | NP | denotes | 10(-7) M all-trans retinoic acid (all-trans RA) |
| C6 | 327-353 | NP | denotes | neutrophil differentiation |
| C7 | 378-421 | NP | denotes | 10(-7) M 1 alpha,25 dihydroxyvitamin D3(D3) |
| C8 | 430-463 | NP | denotes | differentiation towards monocytes |
| C9 | 497-524 | NP | denotes | serum-free grown HL60 cells |
| C10 | 543-568 | NP | denotes | all-trans RA, at 10(-7) M |
| C11 | 585-611 | NP | denotes | neutrophil differentiation |
| C12 | 656-676 | NP | denotes | the D3 concentration |
| C13 | 690-714 | NP | denotes | monocyte differentiation |
| C14 | 781-810 | NP | denotes | all-trans and 9-cis RA and D3 |
| C15 | 811-816 | NP | denotes | which |
| C16 | 825-864 | NP | denotes | neutrophil and monocyte differentiation |
| C17 | 868-878 | NP | denotes | HL60 cells |
| C18 | 922-949 | NP | denotes | serum-free grown HL60 cells |
| C19 | 955-992 | NP | denotes | 5 x 10(-7) M all-trans RA or 9-cis RA |
| C20 | 1083-1095 | NP | denotes | all-trans RA |
| C21 | 1097-1105 | NP | denotes | 9-cis RA |
| C22 | 1122-1124 | NP | denotes | D3 |
| C23 | 1136-1160 | NP | denotes | monocyte differentiation |
| C24 | 1173-1183 | NP | denotes | HL60 cells |
| C26 | 1257-1259 | NP | denotes | D3 |
| C25 | 1239-1259 | NP | denotes | concentrations of D3 |
| C27 | 1285-1311 | NP | denotes | neutrophil differentiation |
| C28 | 1436-1444 | NP | denotes | 9-cis RA |
| C29 | 1477-1501 | NP | denotes | monocyte differentiation |
| C30 | 1520-1546 | NP | denotes | neutrophil differentiation |
| C31 | 1583-1593 | NP | denotes | HL60 cells |
| C32 | 1612-1635 | NP | denotes | 5 x 10(-7) all-trans RA |
| C34 | 1684-1686 | NP | denotes | D3 |
| C33 | 1666-1686 | NP | denotes | concentrations of D3 |
| C35 | 1901-1948 | NP | denotes | optimal neutrophil and monocyte differentiation |
| C36 | 1952-1962 | NP | denotes | HL60 cells |
| C38 | 2008-2016 | NP | denotes | 9-cis RA |
| C39 | 2020-2032 | NP | denotes | all-trans RA |
| C40 | 2037-2039 | NP | denotes | D3 |
| C37 | 2008-2039 | NP | denotes | 9-cis RA or all-trans RA and D3 |
| C41 | 2099-2111 | NP | denotes | these agents |
| R1 | C4 | C1 | coref-ident | serum-grown HL60 cells,HL60 cells |
| R2 | C7 | C2 | coref-ident | "10(-7) M 1 alpha,25 dihydroxyvitamin D3(D3)","1 alpha,25 dihydroxyvitamin D3" |
| R3 | C9 | C4 | coref-ident | serum-free grown HL60 cells,serum-grown HL60 cells |
| R4 | C10 | C5 | coref-ident | "all-trans RA, at 10(-7) M",10(-7) M all-trans retinoic acid (all-trans RA) |
| R5 | C11 | C6 | coref-ident | neutrophil differentiation,neutrophil differentiation |
| R6 | C13 | C8 | coref-ident | monocyte differentiation,differentiation towards monocytes |
| R7 | C15 | C14 | coref-relat | which,all-trans and 9-cis RA and D3 |
| R8 | C16 | C3 | coref-ident | neutrophil and monocyte differentiation,differentiation towards neutrophils or monocytes |
| R9 | C17 | C1 | coref-ident | HL60 cells,HL60 cells |
| R10 | C18 | C9 | coref-ident | serum-free grown HL60 cells,serum-free grown HL60 cells |
| R11 | C20 | C5 | coref-ident | all-trans RA,10(-7) M all-trans retinoic acid (all-trans RA) |
| R12 | C23 | C13 | coref-ident | monocyte differentiation,monocyte differentiation |
| R13 | C24 | C17 | coref-ident | HL60 cells,HL60 cells |
| R14 | C26 | C22 | coref-ident | D3,D3 |
| R15 | C25 | C12 | coref-ident | concentrations of D3,the D3 concentration |
| R16 | C27 | C11 | coref-ident | neutrophil differentiation,neutrophil differentiation |
| R17 | C28 | C21 | coref-ident | 9-cis RA,9-cis RA |
| R18 | C29 | C23 | coref-ident | monocyte differentiation,monocyte differentiation |
| R19 | C30 | C27 | coref-ident | neutrophil differentiation,neutrophil differentiation |
| R20 | C31 | C24 | coref-ident | HL60 cells,HL60 cells |
| R21 | C32 | C19 | coref-ident | 5 x 10(-7) all-trans RA,5 x 10(-7) M all-trans RA or 9-cis RA |
| R22 | C34 | C26 | coref-ident | D3,D3 |
| R23 | C33 | C25 | coref-ident | concentrations of D3,concentrations of D3 |
| R24 | C35 | C16 | coref-ident | optimal neutrophil and monocyte differentiation,neutrophil and monocyte differentiation |
| R25 | C36 | C31 | coref-ident | HL60 cells,HL60 cells |
| R26 | C38 | C28 | coref-ident | 9-cis RA,9-cis RA |
| R27 | C39 | C5 | coref-ident | all-trans RA,10(-7) M all-trans retinoic acid (all-trans RA) |
| R28 | C40 | C34 | coref-ident | D3,D3 |
| R29 | C37 | C14 | coref-ident | 9-cis RA or all-trans RA and D3,all-trans and 9-cis RA and D3 |
| R30 | C41 | C37 | coref-ident | these agents,9-cis RA or all-trans RA and D3 |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-23 | cell_line | denotes | HL60 cells |
| T2 | 53-62 | other_organic_compound | denotes | retinoids |
| T3 | 67-97 | lipid | denotes | 1 alpha,25 dihydroxyvitamin D3 |
| T4 | 133-144 | cell_type | denotes | neutrophils |
| T5 | 148-157 | cell_type | denotes | monocytes |
| T6 | 192-201 | other_name | denotes | apoptosis |
| T7 | 243-254 | cell_line | denotes | serum-grown |
| T8 | 255-265 | cell_line | denotes | HL60 cells |
| T9 | 280-303 | other_organic_compound | denotes | all-trans retinoic acid |
| T10 | 305-317 | other_organic_compound | denotes | all-trans RA |
| T11 | 327-337 | cell_type | denotes | neutrophil |
| T12 | 387-417 | lipid | denotes | 1 alpha,25 dihydroxyvitamin D3 |
| T13 | 418-420 | lipid | denotes | D3 |
| T14 | 454-463 | cell_type | denotes | monocytes |
| T15 | 497-513 | cell_line | denotes | serum-free grown |
| T16 | 514-524 | cell_line | denotes | HL60 cells |
| T17 | 543-555 | other_organic_compound | denotes | all-trans RA |
| T18 | 585-611 | other_name | denotes | neutrophil differentiation |
| T19 | 621-633 | other_organic_compound | denotes | all-trans RA |
| T20 | 660-662 | lipid | denotes | D3 |
| T21 | 690-698 | cell_type | denotes | monocyte |
| T22 | 808-810 | lipid | denotes | D3 |
| T23 | 840-864 | other_name | denotes | monocyte differentiation |
| T24 | 868-878 | cell_line | denotes | HL60 cells |
| T25 | 922-938 | cell_line | denotes | serum-free grown |
| T26 | 939-949 | cell_line | denotes | HL60 cells |
| T27 | 968-980 | other_organic_compound | denotes | all-trans RA |
| T28 | 984-992 | other_organic_compound | denotes | 9-cis RA |
| T29 | 1017-1043 | other_name | denotes | neutrophil differentiation |
| T30 | 1083-1095 | other_organic_compound | denotes | all-trans RA |
| T31 | 1097-1105 | other_organic_compound | denotes | 9-cis RA |
| T32 | 1122-1124 | lipid | denotes | D3 |
| T33 | 1136-1160 | other_name | denotes | monocyte differentiation |
| T34 | 1173-1183 | cell_line | denotes | HL60 cells |
| T35 | 1200-1208 | other_organic_compound | denotes | 9-cis RA |
| T36 | 1257-1259 | lipid | denotes | D3 |
| T37 | 1285-1311 | other_name | denotes | neutrophil differentiation |
| T38 | 1331-1333 | lipid | denotes | D3 |
| T39 | 1366-1375 | other_name | denotes | apoptosis |
| T40 | 1397-1399 | lipid | denotes | D3 |
| T41 | 1436-1444 | other_organic_compound | denotes | 9-cis RA |
| T42 | 1462-1464 | lipid | denotes | D3 |
| T43 | 1477-1501 | other_name | denotes | monocyte differentiation |
| T44 | 1520-1546 | other_name | denotes | neutrophil differentiation |
| T45 | 1583-1593 | cell_line | denotes | HL60 cells |
| T46 | 1623-1635 | other_organic_compound | denotes | all-trans RA |
| T47 | 1684-1686 | lipid | denotes | D3 |
| T48 | 1688-1712 | other_name | denotes | Cross titration analyses |
| T49 | 1731-1739 | other_organic_compound | denotes | 9-cis RA |
| T50 | 1744-1746 | lipid | denotes | D3 |
| T51 | 1750-1759 | cell_line | denotes | HL60 cell |
| T52 | 1952-1962 | cell_line | denotes | HL60 cells |
| T53 | 2008-2016 | other_organic_compound | denotes | 9-cis RA |
| T54 | 2020-2032 | other_organic_compound | denotes | all-trans RA |
| T55 | 2037-2039 | lipid | denotes | D3 |
| T56 | 2115-2138 | other_name | denotes | differentiation therapy |